CDK1 and glioblastoma: Treatment of glioblastoma cells with AKBA significantly decreased the ratio of p-CKD1/CDK1 and cyclin B1 suggesting that AKBA arrested the cell cycle at the G2/M phase, thereby inhibiting cell proliferation.